Research Papers

18 of 43 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
A systematic review and meta-analysis of the sensitivity of antibody tests for the laboratory confirmation of COVID-19.
Makoah NA; Tipih T; Litabe MM; Brink M; Sempa JB; Goedhals D; Burt FJ.
Future Virol (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
A plain language summary of how well the single-dose Janssen vaccine works and how safe it is.
Sadoff J; Struyf F; Douoguih M.
Future Virol (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
Temporal variations of country-specific mutational profile of SARS-CoV-2: effect on vaccine efficacy.
Laha S; Chatterjee R.
Future Virol (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
The importance of determining the amount of 'therapeutic units' before using convalescent plasma.
Vieira YR; Fernandes J; Pinto MA; Sampaio de Lemos ER; Guterres A.
Future Virol (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
In-hospital clinical complications of COVID-19: a brief overview.
John KJ; Nayar J; Mishra AK; Selvaraj V; Khan MS; Lal A.
Future Virol (Unknown)
Published: 2021
1/6 Transparent
Potential drugs against COVID-19 revealed by gene expression profile, molecular docking and molecular dynamic simulatio…
Cava C; Bertoli G; Castiglioni I.
Future Virol (Unknown)
Published: 2021
1/6 Transparent
Association of anemia and COVID-19 in hospitalized patients.
Chen C; Zhou W; Fan W; Ning X; Yang S; Lei Z; Zheng C.
Future Virol (Unknown)
Published: 2021
2/6 Transparent
Druggability of cavity pockets within SARS-CoV-2 spike glycoprotein and pharmacophore-based drug discovery.
Mohebbi A; Askari FS; Sammak AS; Ebrahimi M; Najafimemar Z.
Future Virol (Unknown)
Published: 2021
2/6 Transparent
A comprehensive review about SARS-CoV-2.
Haque SM; Ashwaq O; Sarief A; Azad John Mohamed AK.
Future Virol (Unknown)
Published: 2020
1/6 Transparent
Investigation of compatibility of severe acute respiratory syndrome coronavirus 2 reverse transcriptase-PCR kits contai…
Sarıgül F; Doluca O; Akhan S; Sayan M.
Future Virol (Unknown)
Published: 2020
1/6 Transparent
Membrane binding proteins of coronaviruses.
J Alsaadi EA; Jones IM.
Future Virol (Unknown)
Published: 2019
1/6 Transparent
Middle East respiratory syndrome: pathogenesis and therapeutic developments.
Choudhry H; Bakhrebah MA; Abdulaal WH; Zamzami MA; Baothman OA; Hassan MA; Zeyadi M; Helmi N; Alzahrani F; Ali A; Zakaria MK; Kamal MA; Warsi MK; Ahmed F; Rasool M; Jamal MS.
Future Virol (Unknown)
Published: 2019
2/6 Transparent
Funding Declared
Post-translational modifications of coronavirus proteins: roles and function.
Fung TS; Liu DX.
Future Virol (Unknown)
Published: 2018
2/6 Transparent
Funding Declared
Defective (interfering) viral genomes re-explored: impact on antiviral immunity and virus persistence.
Manzoni TB; López CB.
Future Virol (Unknown)
Published: 2018
2/6 Transparent
Funding Declared
Targeting HPV16 DNA using CRISPR/Cas inhibits anal cancer growth <i>in vivo</i>.
Hsu DS; Kornepati AV; Glover W; Kennedy EM; Cullen BR.
Future Virol (Unknown)
Published: 2018
2/6 Transparent
Funding Declared
HIV-1 latent reservoir: size matters.
Hodel F; Patxot M; Snäkä T; Ciuffi A.
Future Virol (Unknown)
Published: 2016
1/6 Transparent
What needs to be done to control the spread of Middle East respiratory syndrome coronavirus?
Edelstein M; Heymann DL.
Future Virol (Unknown)
Published: 2015
1/6 Transparent
Renin-angiotensin system in human coronavirus pathogenesis.
Wevers BA; van der Hoek L.
Future Virol (Unknown)
Published: 2010
2/6 Transparent
Funding Declared